Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A simple blood test can give an accurate pointer of when a woman will hit the menopause, according to research to be presented at a fertility conference here on Monday.
If confirmed by other scientists, the test devised by Iranian doctors would be a boon for women seeking to plan when to start a family, the European Society of Human Reproduction and Embryology (ESHRE) said in a press release on Sunday.
The test is based on levels of so-called anti-Mullerian hormone (AMH), which controls the development of egg-making cells in the ovary.
A team led by Fahimeh Ramezani Tehrani, a professor at the Shahid Beheshti University of Medical Sciences in Tehran, took blood samples at three yearly intervals among 266 women aged 20 to 49 who were enrolled in a different project launched in 1998.
The women also had physical examinations every three years.
The investigators developed a statistical model that looked at changes in AMH levels and predicted when menopause would take effect.
Sixty-three of the women reached menopause during the study's duration, and the predictions were extremely accurate, Ramezani Tehrani said.
"The average difference between the predicted age at menopause using our model and the women's actual age was only a third of a year," she said.
The maximum margin of error was three to four years.
If a 20-year-old woman has 4.1 nanograms per millitre of AMH, or less, in her blood sample, she is a higher risk of early menopause, meaning before the age of 45.
In contrast, AMH levels of at least 4.5 nanograms per millilitre of AMH at the age of 20, followed by 3.8 nanogramms at the age of 25 and 2.9 nanograms at the age of 30 suggest that menpause will occur beyond the age of 50.
"Our findings indicate that AMH is capable of specifying a woman's reproductive status more realistically than chronological age per se," said Ramezani Tehrani.
Further work is needed among a larger group of women in their twenties to confirm the accuracy of the technique, she added.
The ESHRE conference, gathering thousands of European fertility specialists, continues in Rome until Wednesday.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments